Skip to main content
. 2012 Nov 19;1(2):326–330. doi: 10.3892/mco.2012.40

Table III.

Frequency of CTA expression in each type of cancer.

Antigen RCC (n=35) n (%) HNC (n=40) n (%) P-value
MAGE-A4
  Positive 0 (0) 17 (42.5) <0.001
  Negative 35 (100) 23 (57.5)
NY-ESO-1
  Positive 2 (5.7) 8 (20) 0.09
  Negative 33 (94.3) 32 (80.0)
SAGE
  Positive 1 (2.9) 6 (15.0) 0.11
  Negative 34 (97.1) 34 (85.0)

CTAs, cancer-testis antigens. RCC, renal cell carcinoma; HNC, head and neck cancer.